-
Neoadjuvant ipilimumab plus nivolumab in melanoma: 5-year survival and biomarker analysis from the phase 2 PRADO-trial
Hoeijmakers, L. L., Dimitriadis, P., Wijnen, S. C. M. A., Reijers, I. L. M., Lopez-Yurda, M., Menzies, A. M., Broeks, A., Cornelissen, S., Torres Acosta, A., van der Wal, A., Saw, R. P. M., Versluis, J. M., van Houdt, W. J., Wouters, M. W., Romano, J., Rozeman, E. A., Grijpink-Ongering, L. G., Kapiteijn, E., van der Veldt, A. A. M. & Suijkerbuijk, K. P. M. & 23 others, , 28 Jan 2026, (E-pub ahead of print) In: Nature Medicine.Research output: Contribution to journal › Article › Academic › peer-review
-
SPECT/CT-based sentinel node procedure to guide unilateral elective nodal irradiation in patients with head and neck cancer: technical feasibility and sentinel node mapping outcomes
Al-Mamgani, A., Zwijnenburg, E., Karssemakers, L., Owers, E., Honing, J., Arens, A. I. J., Donswijk, M. L., Smit, L., Navran, A., Klop, W. M., Vogel, W. V., de Veij Mestdagh, P. D., Kaanders, J. H. A. M. & Schreuder, W. H., 8 Nov 2025, (E-pub ahead of print) In: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS).Research output: Contribution to journal › Article › Academic › peer-review
-
Impact of personalized response-directed surgery and adjuvant therapy on survival after neoadjuvant immunotherapy in stage III melanoma: Comparison of 3-year data from PRADO and OpACIN-neo
Reijers, I. L. M., Menzies, A. M., Lopez-Yurda, M., Versluis, J. M., Rozeman, E. A., Saw, R. P. M., van Houdt, W. J., Kapiteijn, E., van der Veldt, A. A. M., Suijkerbuijk, K. P. M., Eriksson, H., Hospers, G. A. P., Klop, W. M. C., Torres Acosta, A., Grijpink-Ongering, L., Gonzalez, M., van der Wal, A., Al-Mamgani, A., Spillane, A. J. & Scolyer, R. A. & 4 others, , Jan 2025, In: European journal of cancer (Oxford, England. 214, p. 115141 115141.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
